Clinical Trial Update: The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour. [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics and safety of olaparib alone and with paclitaxel in Chinese patients with advanced solid tumours.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumours

Drugs mentioned

• Olaparib (Olaparib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Solid Tumours | Phase 1 | Status: COMPLETED | Results posted: 2018-09-13